Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Myofibroma × Laparoscopy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colonic Neoplasms 13 Colorectal Neoplasms 12 Rectal Neoplasms 11 Stomach Neoplasms 9 Ovarian Neoplasms 5 Pancreatic Neoplasms 3 Gastrointestinal Stromal Tumors 3 Carcinoma, Renal Cell 3 Neoplastic Cells, Circulating 2 Neoplasms 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Urinary Incontinence 1 Surgical Wound Infection 1 Sexual Dysfunction, Physiological 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Ovarian Cysts 1 Obesity, Morbid 1 Neoplasm Metastasis 1 Myofibroma 1 Malignant Neoplasm of Transverse Colon 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Locally Advanced Pancreatic Adenocarcinoma 1 Liver Neoplasms 1 Liver Diseases 1

Interventions

Saline Solution 3 relugolix 2 dienogest 2 carbetocin 2 Uterine Myomectomy 2 Uterine Artery Embolization 2 Tranexamic Acid 2 Tourniquets 2 Misoprostol 2 Lidocaine 2 Ascorbic Acid 2 ulipristal 1 telapristone acetate 1 ramosetron 1 pirfenidone 1 estradiol, norethindrone drug combination 1 Vasopressins 1 Triptorelin Pamoate 1 Tablets 1 Sodium Chloride 1 Sevoflurane 1 Respiration, Artificial 1 Remifentanil 1 Propofol 1 Population Groups 1 Nuclear Receptor Subfamily 4, Group A, Member 2 1 Morcellation 1 Methylergonovine 1 Leuprolide 1 Laparoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06067971 2025-09-12

ENDORA2

University Hospital, Clermont-Ferrand

Phase NA Completed

Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡